Literature DB >> 19668627

The impact of HIV/AIDS on children in developing countries.

Joanne Embree1.   

Abstract

HIV infection and AIDS among children continues to be a significant problem in developing countries despite the progress that has been made in HIV prevention and AIDS treatment elsewhere during the past two decades. The reasons for this difference are complex and multifactorial. They include the higher background prevalence of infection among adults in some communities in developing countries, the slow implementation in many countries of prenatal HIV screening programs and prophylaxis which can reduce the transmission to infants during labor and delivery, the social and health consequences of not breastfeeding, and the economic realities associated with expensive diagnostic testing and antiretroviral treatment. While the world waits for an effective HIV/AIDS vaccine, to reduce the prevalence of HIV in the community, public health programs need to continue to emphasize proven methods of HIV transmission prevention among groups with a high-risk of HIV acquisition, as well as provide counselling for the general population about personal protection and the provision of compassionate care for those affected.

Entities:  

Keywords:  HIV infection; Paediatric AIDS; Public health policies

Year:  2005        PMID: 19668627      PMCID: PMC2722540     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  20 in total

1.  Low efficacy of nevirapine (HIVNET012) in preventing perinatal HIV-1 transmission in a real-life situation.

Authors:  Ann Quaghebeur; Lillian Mutunga; Fabian Mwanyumba; Kishor Mandaliya; Chris Verhofstede; Marleen Temmerman
Journal:  AIDS       Date:  2004-09-03       Impact factor: 4.177

2.  Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy.

Authors:  Fiona E Lyons; Suzie Coughlan; Christina M Byrne; Susan M Hopkins; William W Hall; Fiona M Mulcahy
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

3.  Bacteremia among children admitted to a rural hospital in Kenya.

Authors:  James A Berkley; Brett S Lowe; Isaiah Mwangi; Thomas Williams; Evasius Bauni; Saleem Mwarumba; Caroline Ngetsa; Mary P E Slack; Sally Njenga; C Anthony Hart; Kathryn Maitland; Mike English; Kevin Marsh; J Anthony G Scott
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

4.  Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children.

Authors:  T E Taha; N I Kumwenda; R L Broadhead; D R Hoover; S M Graham; L Van Der Hoven; D Markakis; G N Liomba; J D Chiphangwi; P G Miotti
Journal:  Pediatr Infect Dis J       Date:  1999-08       Impact factor: 2.129

5.  Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study.

Authors:  P Datta; J E Embree; J K Kreiss; J O Ndinya-Achola; M Braddick; M Temmerman; N J Nagelkerke; G Maitha; K K Holmes; P Piot
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

6.  Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.

Authors:  Taha E Taha; Newton I Kumwenda; Donald R Hoover; Susan A Fiscus; George Kafulafula; Chiwawa Nkhoma; Samah Nour; Shu Chen; George Liomba; Paolo G Miotti; Robin L Broadhead
Journal:  JAMA       Date:  2004-07-14       Impact factor: 56.272

7.  Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

Authors:  Gonzague Jourdain; Nicole Ngo-Giang-Huong; Sophie Le Coeur; Chureeratana Bowonwatanuwong; Pacharee Kantipong; Pranee Leechanachai; Surabhon Ariyadej; Prattana Leenasirimakul; Scott Hammer; Marc Lallemant
Journal:  N Engl J Med       Date:  2004-07-09       Impact factor: 91.245

8.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Authors:  J Brooks Jackson; Philippa Musoke; Thomas Fleming; Laura A Guay; Danstan Bagenda; Melissa Allen; Clemensia Nakabiito; Joseph Sherman; Paul Bakaki; Maxensia Owor; Constance Ducar; Martina Deseyve; Anthony Mwatha; Lynda Emel; Corey Duefield; Mark Mirochnick; Mary Glenn Fowler; Lynne Mofenson; Paolo Miotti; Maria Gigliotti; Dorothy Bray; Francis Mmiro
Journal:  Lancet       Date:  2003-09-13       Impact factor: 79.321

9.  The natural history of human immunodeficiency virus 1 infection in Haitian infants.

Authors:  S S Jean; J W Pape; R I Verdier; G W Reed; C Hutto; W D Johnson; P F Wright
Journal:  Pediatr Infect Dis J       Date:  1999-01       Impact factor: 2.129

10.  Pathology and causes of death in a series of human immunodeficiency virus-positive and -negative pediatric referral hospital admissions in Botswana.

Authors:  Naseem A Ansari; Ally H Kombe; Thomas A Kenyon; Loeto Mazhani; Nancy Binkin; Jordan W Tappero; Tesfaye Gebrekristos; Samabyawo Nyirenda; Sebastian B Lucas
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

View more
  2 in total

1.  Association Between Maternal HIV Stigma Among South Indian Mothers Living with HIV and the CD4 Count of Children Living with HIV.

Authors:  Valerie PhamDo; Adeline M Nyamathi; Maria L Ekstrand; Sanjeev Sinha; Kartik Yadav; Sanghyuk S Shin
Journal:  AIDS Behav       Date:  2021-12-11

2.  Transition of children with life-limiting conditions to adult care and healthcare use: a systematic review.

Authors:  Stuart W Jarvis; Daniel Roberts; Kate Flemming; Gerry Richardson; Lorna K Fraser
Journal:  Pediatr Res       Date:  2021-03-02       Impact factor: 3.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.